Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs

With the development of poly(ADP-ribose) polymerase inhibitors, the treatment of advanced ovarian cancer is changing dramatically. The purpose of this narrative review is to provide a direction for the individualization of advanced ovarian cancer treatment based on the mechanism of action of molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakai, Hidekatsu, Matsumura, Noriomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006498/
https://www.ncbi.nlm.nih.gov/pubmed/35416600
http://dx.doi.org/10.1007/s10147-022-02163-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006498/
https://www.ncbi.nlm.nih.gov/pubmed/35416600
http://dx.doi.org/10.1007/s10147-022-02163-3

Ejemplares similares